WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

This dual-imaging approach could lead to more precise, less invasive skin cancer diagnostics in the future. By combining structural and chemical information, clinicians may be able to make faster and ...

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

Skin cancer is the most common form of cancer worldwide, and early detection is key to successful treatment. While ...

Researchers have developed a compact, noninvasive imaging system that combines high-resolution structural imaging with ...

This meta-analysis demonstrated the clinical efficacy and safety of cancer vaccines in advanced NSCLC patients after first-line therapy, especially in those with squamous cell carcinoma. Immune ...

One of the biggest contributors to skin cancer in Uganda is exposure to ultraviolet (UV) radiation from the sun. Uganda’s location along the equator results in high levels of year-round sunlight.

SkyMD, a leading provider of innovative dermatological services, today announced the grand opening of its new clinic in Albuquerque, New Mexico. Located at 101 Hospital Loop NE #114, Albuquerque, NM ...

PSMA and Beyond 2025 CA-IX in renal cell cancer (RCC), ZIRCON, kidney cancer, stage migration for RCC, REDECT trial, renal mass biopsy, girentuximab.

Dual integrin α5β1/αv targeting with a bispecific antibody represents a novel therapeutic strategy that reprograms the epigenetic and transcriptomic signatures of basal-type prostate cancer with ...

A new study from ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute sheds new light on why certain areas of Delaware face ...